Recently, a clinical trial reported that treatment with G-CSF improved survival in patients with severe alcoholic hepatitis,39 which may be mediated via the G-CSF activation of neutrophils and subsequent inhibition of bacterial infection.40 This evidence concerns the gene CSF3 and bacterial infectious disease.